Seeyond United Therapeutics Corp Transaction History

Seeyond

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$74.85 - $85.99 $362,723 - $416,707	-4,846 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $694,123 - $1.1 Million	-9,126 Reduced 65.32%	4,846 $378,000
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $1.22 Million - $1.45 Million	11,405 Added 444.29%	13,972 $1.64 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $260,293 - $330,449	2,567 New	2,567 $280,000

667

42.7M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

Stay updated on Seeyond with notifications on news.